ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Metrics to compare | ANIP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANIPPeersSector | |
---|---|---|---|---|
P/E Ratio | −69.5x | 15.4x | −0.5x | |
PEG Ratio | 0.31 | 0.02 | 0.00 | |
Price / Book | 3.5x | 2.4x | 2.6x | |
Price / LTM Sales | 2.3x | 3.9x | 2.9x | |
Upside (Analyst Target) | 21.9% | 148.0% | 60.8% | |
Fair Value Upside | Unlock | 18.1% | 10.8% | Unlock |